STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 225 participants.
Also called NCT03118518
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 225 participants
- Registry
-
NCT03118518
-
- Other papers using this trial's data
- Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03118518. Randomized; no masking; primary purpose treatment. Start 2017-06-23 (actual); primary completion 2020-06-25 (actual). Results posted on 2021-08-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation
- Acronym
- STOP AF First
- Condition
- Atrial Fibrillation
- Condition
- Atrial Fibrillation New Onset
- Intervention (Device)
- Cryoablation
- Intervention (Drug)
- Antiarrhythmic drug
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct03118518- Content hash
cfd5724781e7fcf714359e2fd13f0a23dfb86bf5ad56b01d94b64fe11e7745e1